相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发:CHO 培养基是如何实现产量提升Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
- 库存:
货期:询盘
- 供应商:
MedChemExpress LLC
- CAS号:
2096999-92-5
- 规格:
询盘
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
JAK-IN-5
CAS No. : 2096999-92-5
MCE 国际站:JAK-IN-5
产品活性:JAK-IN-5 是 JAK 的抑制剂,来自专利US20170121327A1,化合物实例 283。
研究领域:Epigenetics | Protein Tyrosine Kinase/RTK | JAK/STAT Signaling | Stem Cell/Wnt
作用靶点:JAK
In Vivo: JAK-IN-5 (compound 1) (oral aspirate, 0.5 mg/mL, 50 μL ) inhibits STAT6 phosphorylation by 60% in IL-13-induced in lung tissue in a mouse model of pSTAT6 induction.
JAK-IN-5 (compound 1) (oral aspirate, 0.1-1.0 mg/mL, 50 μL) inhibits 88% of BALF eosinophils in male C57 mice model of Alternaria alternata-induced eosinophilic inflammation of the lung.
相关产品:Ruxolitinib | Tofacitinib | Deucravacitinib | Baricitinib | AG490 | Upadacitinib | Fedratinib | Pacritinib | Ritlecitinib | Momelotinib | WP1066 | Filgotinib | Butyzamide | RO8191 | AZD-1480 | AT9283 | Peficitinib | Abrocitinib | Itacitinib | Cucurbitacin I | CHZ868 | (E/Z)-Zotiraciclib | Pyridone 6 | Gandotinib | JAK2 JH2 Tracer | Atractylenolide I
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验血清及1%双抗,置于37℃、5%CO₂培养箱中培养。传代比例1:2到1:4,周期2-3天,密度不宜过高。传代时先用PBS轻轻润洗10-20秒,加胰酶消化至细胞间隙变大即加入完全培养基终止,900rpm离心3-5分钟,吹打需轻柔避免气泡。冻存液推荐92%FBS加8%DMSO或92%完全培养基加8%DMSO,密度控制在200-300万/mL,程序降温后转入液氮,-80℃暂存不超过3天。复苏时37℃水浴2分钟内快速融化,5-10分钟内完成接种。收货时常温细胞需静置2-4小时,原瓶培养基可离心取上清4℃保存用于过渡
cells, including basophils and dendritic cells, might contribute to the polarization of TH2 cells. IL-33 exerts dual functions on TH2 cells: it acts not only as an activator and chemoattractant, but also as a regulator, by reducing production of IL-5
(1.30-5.60)122±0.98125±0.96(120-146)4.87±0.845.06±0.93(3.80-7.95)92.3±1.0496.5±1.19(90.0-115)22.0±4.0020.9±3.80(12.8-30.0)5.33±1.155.30±1.10(3.00-7.63)9.60±0.6310.7±0.58(8.30-12.0)2.35±0.252.46±0.27(1.80-3.00)兔0.32±0.040.30±0.04(0.00-0.74)26.7±12.924.5±
技术资料暂无技术资料 索取技术资料


















